Journal article
Predicting homologous recombination deficiency and treatment responses using a computed tomography-based foundation model: a preclinical study
- Abstract:
- Homologous recombination deficiency (HRD) can lead to genomic instability, increased cancer susceptibility, and enhanced sensitivity to DNA-targeting therapies. Although radiomics has been used for various medical applications, its application in animal studies remains largely unexplored, primarily due to the typically limited availability of preclinical data. In this study, we applied a state-of-the-art foundation model (FM) on preclinical computed tomography (CT) images in mice, aiming to: (i) distinguish HRD status within isogenic xenografts, and (ii) predict differential therapeutic responses of CP-506, a novel hypoxia-activated DNA-crosslinking agent. The dataset comprises micro-CT scans of 307 mice with balanced HRD status, collected both before and after CP-506 or control treatment. The FM demonstrated robust HRD classification performance, achieving an AUC of 0.88 on the test set, which significantly outperformed the handcrafted radiomics and supervised deep learning (sDL). The highest AUC (0.93) was achieved in the consensus subgroup (71%) between sDL and FM. Additionally, HRD-related features predicted DNA damage and growth delay following the treatment. Interpretability analysis indicated the important role of texture heterogeneity in HRD classification. Therefore, these results suggest that FM successfully overcomes the data scarcity in animal studies and enables HRD classification and treatment response prediction from preclinical CT imaging.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.9MB, Terms of use)
-
(Preview, Other, pdf, 1.5MB, Terms of use)
-
- Publisher copy:
- 10.1038/s41698-026-01322-3
Authors
+ Dutch Cancer Society
More from this funder
- Funder identifier:
- https://ror.org/0368jnd28
- Grant:
- 14449/2021-PoC
- Publisher:
- Nature Research
- Journal:
- npj Precision Oncology More from this journal
- Volume:
- 10
- Issue:
- 1
- Article number:
- 121
- Publication date:
- 2026-02-10
- Acceptance date:
- 2026-01-28
- DOI:
- EISSN:
-
2397-768X
- ISSN:
-
2397-768X
- Language:
-
English
- Keywords:
- Pubs id:
-
2376576
- Local pid:
-
pubs:2376576
- Source identifiers:
-
3868939
- Deposit date:
-
2026-03-19
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2026
If you are the owner of this record, you can report an update to it here: Report update to this record